Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions
NCT ID: NCT04945174
Last Updated: 2025-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2022-06-01
2033-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivators and Barriers for Physical Activity in Patients With Minor Stroke
NCT04332458
MONitoring Sedentary Behavior and Light Physical Activity in Patients With Stroke
NCT05793177
ExStroke Pilot Trial: Physical Exercise After Acute Ischaemic Stroke
NCT00132483
The Effect of Aerobic Exercise in Patients With Lacunar Stroke
NCT02731235
Pre-stroke Physical Activity in Patients With Stroke
NCT05051111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim is to develop and evaluate a standardized exercise program (a stroke school) for patients with minor stroke or TIA. The intervention consist of 6 weeks of supervised aerobic exercise at the hospital combined with patient education including knowledge on stroke risk factors. Subsequently, 6 weeks of supervised aerobic exercise in their local municipality. After the 12 weeks of exercise, patients are offered individual, motivational follow-up sessions with the purpose to facilitate the patients to stay physically active in their everyday life.
This intervention will increase the patients´ knowledge regarding risk factors for stroke and cardiovascular disease, increase their cardiorespiratory fitness and facilitate the patients to be physical active and hopefully slow the progression of vascular disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
12 weeks of supervised cardiorespiratory exercise twice a week (6 weeks at the hospital and 6 weeks in the local municipality) combined with patient education and individual follow-up sessions
Cardiorespiratory exercise combined with patient education and individual follow-up sessions
6 weeks of cardiorespiratory exercise combined with patient education at the hospital, followed by 6 weeks of cardiorespiratory exercise in the local municipality. Subsequently individual follow-up sessions with the aim to facilitate the patients to stay physically active in their everyday life
Usual care
The usual care group is encouraged to perform home-based aerobic exercise on their own
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiorespiratory exercise combined with patient education and individual follow-up sessions
6 weeks of cardiorespiratory exercise combined with patient education at the hospital, followed by 6 weeks of cardiorespiratory exercise in the local municipality. Subsequently individual follow-up sessions with the aim to facilitate the patients to stay physically active in their everyday life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients spending ≤ 5 hour of leisure time on high-intensity physical activity on weekly basis within the last 3 months
* Able to speak and read Danish and to provide informed consent
* Individuals ≥ 18 years of age
Exclusion Criteria
* Unstable cardiac condition, e.g. pacemaker
* Uncontrolled hypertension (patients not responding adequately to antihypertensive medication when applying treatment according to guidelines)
* Symptoms or comorbidities not allowing exercise on a stationary bicycle (e.g. claudication)
* Dyspnoea caused by heart or pulmonary disease (e.g. COPD)
* Aphasia, or dementia that interferer with understanding the protocol and/or physical examinations.
* Patients diagnosed with dementia at hospital admission (a score ≤23/30 on the Mini-Mental State Examination are not invited into the study)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christina Kruuse
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christina Kruuse, Professor
Role: PRINCIPAL_INVESTIGATOR
Herlev Gentofte Hospital, Department of Neurology
Anders Hougaard, MD, Ph.d.
Role: STUDY_DIRECTOR
Herlev Gentofte hospital, Department of Neurology,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herlev Hospital
Copenhagen, Herlev, Denmark
Department of Neurology, Herlev-Gentofte Hospital
Herlev, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Christina Kruuse, MD, DMSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-20059985
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.